Organ-level tissue engineering using bioreactor systems and stem cells: implications for transplant surgery

Area of Science:

• Regenerative Medicine
• Transplantation Immunology
• Biotechnology

Background:

• Vascularized composite allotransplantation (VCA) offers solutions for complex reconstructions beyond traditional methods.
• Current limitations in VCA include logistical hurdles and significant immunologic challenges.
• Stem cells and tissue engineering present new avenues for VCA advancement.

Purpose of the Study:

• To explore the potential of bioreactor technology in overcoming VCA limitations.
• To investigate methods for mitigating immunogenicity and enhancing graft function in VCA.
• To assess the feasibility of de novo tissue generation using bioreactors for VCA.

Main Methods:

• Utilizing bioreactors to prolong ex vivo allograft survival.
• Implementing bioreactor systems for stem cell seeding of vascularized bioscaffolds.
• Developing allograft modulations within bioreactors to reduce immunogenicity.

Main Results:

• Bioreactors demonstrate potential for extending allograft survival ex vivo.
• Stem cell seeding in bioreactors offers a pathway for generating complex vascularized tissues.
• Bioreactor-based strategies show promise in mitigating immune responses and improving graft function.

Conclusions:

• Bioreactor technology is a key innovation for advancing vascularized composite allotransplantation.
• These strategies may expand the reconstructive capabilities of VCA.
• Future applications include the fabrication of customized complex tissue grafts.